PMC5079238_01
CT abdomen/pelvis on initial presentation, axial (A,B) and coronal (C). These images demonstrate the duodenal mass (A, C), and the pelvic mass (B), which were identified at presentation, the red arrows point to the "duodenal mass," and "pelvic mass".
gr1.jpg
PMC5079238_01_gr1.jpg
fig1
Computed tomography (CT) demonstrated a 16 cm distal gastric mass and a 7 cm pelvic mass (Fig. 1A-C).
Bone scan demonstrating T11 lesion, the red arrow points to the "T11 lesion".
gr2.jpg
PMC5079238_01_gr2.jpg
fig2
T11 lytic lesion concerning for pathologic compression fracture (Fig. 2).
CT (A) and MRI (B) after BEP x 4 cycles, demonstrating growing teratoma the red arrows point to the "growing teratoma".
gr3.jpg
PMC5079238_01_gr3.jpg
fig3
Postchemotherapy imaging demonstrated disease progression despite chemotherapy, with interval progression from 8.4 x 7 x 5.6 cm to 10 x 8 x 8.1 cm, and multiple new liver metastases (Fig. 3A). MRI of the pelvis was performed for surgical planning (Fig. 3B).